Vanoxerine (BioDeep_00001871433)
代谢物信息卡片
Vanoxerine
化学式: C28H32F2N2O (450.2483)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
InChI: InChI=1S/C28H32F2N2O/c29-26-12-8-24(9-13-26)28(25-10-14-27(30)15-11-25)33-22-21-32-19-17-31(18-20-32)16-4-7-23-5-2-1-3-6-23/h1-3,5-6,8-15,28H,4,7,16-22H2
描述信息
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors
C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents
D049990 - Membrane Transport Modulators
同义名列表
1 个代谢物同义名
数据库引用编号
6 个数据库交叉引用编号
- ChEBI: CHEBI:64089
- PubChem: 3455
- DrugBank: DB03701
- ChEMBL: CHEMBL281594
- CAS: 110872-73-6
- CAS: 67469-69-6
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
Cell reports.
2021 04; 35(4):109040. doi:
10.1016/j.celrep.2021.109040. [PMID: 33910017] - Magdalena Górny, Agnieszka Wnuk, Adrianna Kamińska, Kinga Kamińska, Grażyna Chwatko, Anna Bilska-Wilkosz, Małgorzata Iciek, Małgorzata Kajta, Zofia Rogóż, Elżbieta Lorenc-Koci. Glutathione Deficiency and Alterations in the Sulfur Amino Acid Homeostasis during Early Postnatal Development as Potential Triggering Factors for Schizophrenia-Like Behavior in Adult Rats.
Molecules (Basel, Switzerland).
2019 Nov; 24(23):. doi:
10.3390/molecules24234253. [PMID: 31766654] - Juliana R Bastos, Katherinne M Perico, Érica L Marciano Vieira, Antônio L Teixeira, Fabiana S Machado, Aline S de Miranda, Fabrício A Moreira. Inhibition of the dopamine transporter as an animal model of bipolar disorder mania: Locomotor response, neuroimmunological profile and pharmacological modulation.
Journal of psychiatric research.
2018 07; 102(?):142-149. doi:
10.1016/j.jpsychires.2018.04.004. [PMID: 29656188] - Nadia Giordano, Attilio Iemolo, Maria Mancini, Fabrizio Cacace, Maria De Risi, Emanuele Claudio Latagliata, Veronica Ghiglieri, Gian Carlo Bellenchi, Stefano Puglisi-Allegra, Paolo Calabresi, Barbara Picconi, Elvira De Leonibus. Motor learning and metaplasticity in striatal neurons: relevance for Parkinson's disease.
Brain : a journal of neurology.
2018 02; 141(2):505-520. doi:
10.1093/brain/awx351. [PMID: 29281030] - Andrew S Felts, Alice L Rodriguez, Ryan D Morrison, Katrina A Bollinger, Daryl F Venable, Anna L Blobaum, Frank W Byers, Analisa Thompson Gray, J Scott Daniels, Colleen M Niswender, Carrie K Jones, P Jeffrey Conn, Craig W Lindsley, Kyle A Emmitte. Discovery of imidazo[1,2-a]-, [1,2,4]triazolo[4,3-a]-, and [1,2,4]triazolo[1,5-a]pyridine-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5.
Bioorganic & medicinal chemistry letters.
2017 11; 27(21):4858-4866. doi:
10.1016/j.bmcl.2017.09.042. [PMID: 28958625] - Egle Janenaite, Valentina Vengeliene, Anton Bespalov, Berthold Behl. Potential role of tyrosine hydroxylase in the loss of psychostimulant effect of amphetamine under conditions of impaired dopamine transporter activity.
Behavioural brain research.
2017 09; 334(?):105-108. doi:
10.1016/j.bbr.2017.07.028. [PMID: 28750831] - C E Terrillion, D T Dao, R Cachope, M K Lobo, A C Puche, J F Cheer, T D Gould. Reduced levels of Cacna1c attenuate mesolimbic dopamine system function.
Genes, brain, and behavior.
2017 06; 16(5):495-505. doi:
10.1111/gbb.12371. [PMID: 28186690] - Jianjing Cao, Rachel D Slack, Oluyomi M Bakare, Caitlin Burzynski, Rana Rais, Barbara S Slusher, Theresa Kopajtic, Alessandro Bonifazi, Michael P Ellenberger, Hideaki Yano, Yi He, Guo-Hua Bi, Zheng-Xiong Xi, Claus J Loland, Amy Hauck Newman. Novel and High Affinity 2-[(Diphenylmethyl)sulfinyl]acetamide (Modafinil) Analogues as Atypical Dopamine Transporter Inhibitors.
Journal of medicinal chemistry.
2016 12; 59(23):10676-10691. doi:
10.1021/acs.jmedchem.6b01373. [PMID: 27933960] - Aviad Hai, Lili X Cai, Taekwan Lee, Victor S Lelyveld, Alan Jasanoff. Molecular fMRI of Serotonin Transport.
Neuron.
2016 Nov; 92(4):754-765. doi:
10.1016/j.neuron.2016.09.048. [PMID: 27773583] - Sarah E Bradshaw, Kara L Agster, Barry D Waterhouse, Jill A McGaughy. Age-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats.
Brain research.
2016 Jun; 1641(Pt B):245-57. doi:
10.1016/j.brainres.2016.01.001. [PMID: 26774596] - Thomas M Jeitner, Mike Kalogiannis, Boris F Krasnikov, Irving Gomolin, Morgan R Peltier, Graham R Moran. Linking Inflammation and Parkinson Disease: Hypochlorous Acid Generates Parkinsonian Poisons.
Toxicological sciences : an official journal of the Society of Toxicology.
2016 06; 151(2):388-402. doi:
10.1093/toxsci/kfw052. [PMID: 27026709] - Manuela Meireles, Eduardo Moura, Maria Augusta Vieira-Coelho, Celestino Santos-Buelga, Susana Gonzalez-Manzano, Montserrat Dueñas, Nuno Mateus, Ana Faria, Conceição Calhau. Flavonoids as dopaminergic neuromodulators.
Molecular nutrition & food research.
2016 Mar; 60(3):495-501. doi:
10.1002/mnfr.201500557. [PMID: 26582321] - Andrew M Novick, Gina L Forster, James E Hassell, Daniel R Davies, Jamie L Scholl, Kenneth J Renner, Michael J Watt. Increased dopamine transporter function as a mechanism for dopamine hypoactivity in the adult infralimbic medial prefrontal cortex following adolescent social stress.
Neuropharmacology.
2015 Oct; 97(?):194-200. doi:
10.1016/j.neuropharm.2015.05.032. [PMID: 26056032] - Ana Isabelle G Queiroz, Maíra Moraes de Araújo, Tatiane da Silva Araújo, Greicy Coelho de Souza, Lígia Menezes Cavalcante, Michel de Jesus Souza Machado, David Freitas de Lucena, João Quevedo, Danielle Macêdo. GBR 12909 administration as an animal model of bipolar mania: time course of behavioral, brain oxidative alterations and effect of mood stabilizing drugs.
Metabolic brain disease.
2015 Oct; 30(5):1207-15. doi:
10.1007/s11011-015-9697-6. [PMID: 26073232] - Christopher W Atcherley, Nicholas D Laude, Eric B Monroe, Kevin M Wood, Parastoo Hashemi, Michael L Heien. Improved Calibration of Voltammetric Sensors for Studying Pharmacological Effects on Dopamine Transporter Kinetics in Vivo.
ACS chemical neuroscience.
2015 Sep; 6(9):1509-16. doi:
10.1021/cn500020s. [PMID: 25062330] - Narasimha M Midde, Yaxia Yuan, Pamela M Quizon, Wei-Lun Sun, Xiaoqin Huang, Chang-Guo Zhan, Jun Zhu. Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport.
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology.
2015 Mar; 10(1):122-35. doi:
10.1007/s11481-015-9583-3. [PMID: 25604666] - Jordy van Enkhuizen, Brook L Henry, Arpi Minassian, William Perry, Morgane Milienne-Petiot, Kerin K Higa, Mark A Geyer, Jared W Young. Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
2014 Dec; 39(13):3112-22. doi:
10.1038/npp.2014.170. [PMID: 25005251] - Vincent D Costa, Valery L Tran, Janita Turchi, Bruno B Averbeck. Dopamine modulates novelty seeking behavior during decision making.
Behavioral neuroscience.
2014 Oct; 128(5):556-66. doi:
10.1037/a0037128. [PMID: 24911320] - Minsoo Han, Chiman Song, Nakcheol Jeong, Hoh-Gyu Hahn. Exploration of 3-Aminoazetidines as Triple Reuptake Inhibitors by Bioisosteric Modification of 3-α-Oxyazetidine.
ACS medicinal chemistry letters.
2014 Sep; 5(9):999-1004. doi:
10.1021/ml500187a. [PMID: 25221656] - Idaira Oliva, Miriam Fernández, Eduardo D Martín. Dopamine release regulation by astrocytes during cerebral ischemia.
Neurobiology of disease.
2013 Oct; 58(?):231-41. doi:
10.1016/j.nbd.2013.06.007. [PMID: 23800715] - Jordy van Enkhuizen, Mark A Geyer, Klaas Kooistra, Jared W Young. Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice.
The international journal of neuropsychopharmacology.
2013 Jun; 16(5):1021-31. doi:
10.1017/s1461145712001198. [PMID: 23164454] - Soyon Ahn, Anthony G Phillips. Daily monitoring of dopamine efflux reveals a short-lasting occlusion of the dopamine agonist properties of d-amphetamine by dopamine transporter blockers GBR 12909 and methylphenidate.
ACS chemical neuroscience.
2013 May; 4(5):817-24. doi:
10.1021/cn400040r. [PMID: 23586444] - Jordy van Enkhuizen, Mark A Geyer, Jared W Young. Differential effects of dopamine transporter inhibitors in the rodent Iowa gambling task: relevance to mania.
Psychopharmacology.
2013 Feb; 225(3):661-74. doi:
10.1007/s00213-012-2854-2. [PMID: 22945515] - Katsura Takano, Nobuyuki Tanaka, Kenji Kawabe, Mitsuaki Moriyama, Yoichi Nakamura. Extracellular superoxide dismutase induced by dopamine in cultured astrocytes.
Neurochemical research.
2013 Jan; 38(1):32-41. doi:
10.1007/s11064-012-0882-2. [PMID: 22983620] - Dmitry M Mebel, Jovi C Y Wong, Yifei J Dong, Stephanie L Borgland. Insulin in the ventral tegmental area reduces hedonic feeding and suppresses dopamine concentration via increased reuptake.
The European journal of neuroscience.
2012 Aug; 36(3):2336-46. doi:
10.1111/j.1460-9568.2012.08168.x. [PMID: 22712725] - Oleg Kovtun, Emily J Ross, Ian D Tomlinson, Sandra J Rosenthal. A flow cytometry-based dopamine transporter binding assay using antagonist-conjugated quantum dots.
Chemical communications (Cambridge, England).
2012 Jun; 48(44):5428-30. doi:
10.1039/c2cc31951a. [PMID: 22543630] - Matthew Benskey, Bahareh Behrouz, Johan Sunryd, Samuel S Pappas, Seung-Hoon Baek, Marianne Huebner, Keith J Lookingland, John L Goudreau. Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression.
Neurotoxicology.
2012 Jun; 33(3):321-31. doi:
10.1016/j.neuro.2012.02.001. [PMID: 22342763] - Dhananjay Sakrikar, Michelle S Mazei-Robison, Marc A Mergy, Nathan W Richtand, Qiao Han, Peter J Hamilton, Erica Bowton, Aurelio Galli, Jeremy Veenstra-Vanderweele, Michael Gill, Randy D Blakely. Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation.
The Journal of neuroscience : the official journal of the Society for Neuroscience.
2012 Apr; 32(16):5385-97. doi:
10.1523/jneurosci.6033-11.2012. [PMID: 22514303] - Ivan Cakulev, Antonio E Lacerda, Celeen M Khrestian, Kyungmoo Ryu, Arthur M Brown, Albert L Waldo. Oral vanoxerine prevents reinduction of atrial tachyarrhythmias: preliminary results.
Journal of cardiovascular electrophysiology.
2011 Nov; 22(11):1266-73. doi:
10.1111/j.1540-8167.2011.02098.x. [PMID: 21615815] - Olof Eriksson, Bengt Långström, Ray Josephsson. Assessment of receptor occupancy-over-time of two dopamine transporter inhibitors by [(11)C]CIT and target controlled infusion.
Upsala journal of medical sciences.
2011 May; 116(2):100-6. doi:
10.3109/03009734.2011.563878. [PMID: 21443419] - Susanna Nencetti, Maria R Mazzoni, Gabriella Ortore, Annalina Lapucci, Janette Giuntini, Elisabetta Orlandini, Irene Banti, Elisa Nuti, Antonio Lucacchini, Gino Giannaccini, Armando Rossello. Synthesis, molecular docking and binding studies of selective serotonin transporter inhibitors.
European journal of medicinal chemistry.
2011 Mar; 46(3):825-34. doi:
10.1016/j.ejmech.2010.12.018. [PMID: 21272963] - Kyle C Schmitt, Maarten E A Reith. The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors.
PloS one.
2011; 6(10):e25790. doi:
10.1371/journal.pone.0025790. [PMID: 22043293] - Fatemeh Talaei, Hjalmar R Bouma, Adrianus C Van der Graaf, Arjen M Strijkstra, Martina Schmidt, Robert H Henning. Serotonin and dopamine protect from hypothermia/rewarming damage through the CBS/H2S pathway.
PloS one.
2011; 6(7):e22568. doi:
10.1371/journal.pone.0022568. [PMID: 21829469] - Theresa A Kopajtic, Yi Liu, Christopher K Surratt, David M Donovan, Amy H Newman, Jonathan L Katz. Dopamine transporter-dependent and -independent striatal binding of the benztropine analog JHW 007, a cocaine antagonist with low abuse liability.
The Journal of pharmacology and experimental therapeutics.
2010 Dec; 335(3):703-14. doi:
10.1124/jpet.110.171629. [PMID: 20855444] - J Park, B J Aragona, B M Kile, R M Carelli, R M Wightman. In vivo voltammetric monitoring of catecholamine release in subterritories of the nucleus accumbens shell.
Neuroscience.
2010 Aug; 169(1):132-42. doi:
10.1016/j.neuroscience.2010.04.076. [PMID: 20451589] - Jared W Young, Mark A Geyer. Action of modafinil--increased motivation via the dopamine transporter inhibition and D1 receptors?.
Biological psychiatry.
2010 Apr; 67(8):784-7. doi:
10.1016/j.biopsych.2009.12.015. [PMID: 20132929] - Jocelien D A Olivier, Alexander R Cools, Peter M T Deen, Berend Olivier, Bart A Ellenbroek. Blockade of dopamine, but not noradrenaline, transporters produces hyperthermia in rats that lack serotonin transporters.
European journal of pharmacology.
2010 Mar; 629(1-3):7-11. doi:
10.1016/j.ejphar.2009.11.049. [PMID: 20004658] - Antonio E Lacerda, Yuri A Kuryshev, Gan-Xin Yan, Albert L Waldo, Arthur M Brown. Vanoxerine: cellular mechanism of a new antiarrhythmic.
Journal of cardiovascular electrophysiology.
2010 Mar; 21(3):301-10. doi:
10.1111/j.1540-8167.2009.01623.x. [PMID: 19817928] - Jared W Young, Andrew K L Goey, Arpi Minassian, William Perry, Martin P Paulus, Mark A Geyer. GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior.
Psychopharmacology.
2010 Feb; 208(3):443-54. doi:
10.1007/s00213-009-1744-8. [PMID: 20020109] - Stefan Schildknecht, Dominik Pöltl, Daniel M Nagel, Florian Matt, Diana Scholz, Julie Lotharius, Nathalie Schmieg, Alberto Salvo-Vargas, Marcel Leist. Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells.
Toxicology and applied pharmacology.
2009 Nov; 241(1):23-35. doi:
10.1016/j.taap.2009.07.027. [PMID: 19647008] - James D White, Rajan Juniku, Kun Huang, Jongtae Yang, David T Wong. Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters.
Journal of medicinal chemistry.
2009 Oct; 52(19):5872-9. doi:
10.1021/jm900847b. [PMID: 19791802] - Andrea Varrone, Carsten Steiger, Magnus Schou, Akihiro Takano, Sjoerd J Finnema, Denis Guilloteau, Balázs Gulyás, Christer Halldin. In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand.
Synapse (New York, N.Y.).
2009 Oct; 63(10):871-80. doi:
10.1002/syn.20670. [PMID: 19562698] - Rebecca A Alyea, Cheryl S Watson. Nongenomic mechanisms of physiological estrogen-mediated dopamine efflux.
BMC neuroscience.
2009 Jun; 10(?):59. doi:
10.1186/1471-2202-10-59. [PMID: 19531209] - Helga Stopper, Nicole Schupp, Gholamreza Fazeli, Barbara Dietel, Nina Queisser, Susanne Walitza, Manfred Gerlach. Genotoxicity of the neurotransmitter dopamine in vitro.
Toxicology in vitro : an international journal published in association with BIBRA.
2009 Jun; 23(4):640-6. doi:
10.1016/j.tiv.2009.03.001. [PMID: 19285549] - Dorota Zolkowska, Raka Jain, Richard B Rothman, John S Partilla, Bryan L Roth, Vincent Setola, Thomas E Prisinzano, Michael H Baumann. Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil.
The Journal of pharmacology and experimental therapeutics.
2009 May; 329(2):738-46. doi:
10.1124/jpet.108.146142. [PMID: 19197004] - Rebecca A Alyea, Cheryl S Watson. Differential regulation of dopamine transporter function and location by low concentrations of environmental estrogens and 17beta-estradiol.
Environmental health perspectives.
2009 May; 117(5):778-83. doi:
10.1289/ehp.0800026. [PMID: 19479021] - Emanuele Seu, Andrew Lang, Ronald J Rivera, J David Jentsch. Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys.
Psychopharmacology.
2009 Jan; 202(1-3):505-19. doi:
10.1007/s00213-008-1250-4. [PMID: 18604598] - Meredith A Fox, Catherine L Jensen, Helen T French, Alison R Stein, Su-Jan Huang, Teresa J Tolliver, Dennis L Murphy. Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice.
Psychopharmacology.
2008 Dec; 201(2):203-18. doi:
10.1007/s00213-008-1268-7. [PMID: 18712364] - Vladimir Stepanov, Jaak Järv. Kinetic mechanism of dopamine transporter interaction with 1-(2-(bis-(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine (GBR 12909).
Neurochemistry international.
2008 Dec; 53(6-8):370-3. doi:
10.1016/j.neuint.2008.09.005. [PMID: 18845198] - Michael Y Aksenov, Marina V Aksenova, Janelle M Silvers, Charles F Mactutus, Rosemarie M Booze. Different effects of selective dopamine uptake inhibitors, GBR 12909 and WIN 35428, on HIV-1 Tat toxicity in rat fetal midbrain neurons.
Neurotoxicology.
2008 Nov; 29(6):971-7. doi:
10.1016/j.neuro.2008.06.003. [PMID: 18606182] - Kyle C Schmitt, Juan Zhen, Prashant Kharkar, Manoj Mishra, Nianhang Chen, Aloke K Dutta, Maarten E A Reith. Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties.
Journal of neurochemistry.
2008 Nov; 107(4):928-40. doi:
10.1111/j.1471-4159.2008.05667.x. [PMID: 18786172] - Jianjing Cao, Theresa Kopajtic, Jonathan L Katz, Amy Hauck Newman. Dual DAT/sigma1 receptor ligands based on 3-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol.
Bioorganic & medicinal chemistry letters.
2008 Oct; 18(19):5238-41. doi:
10.1016/j.bmcl.2008.08.065. [PMID: 18774292] - Pavlos Pissios, Lauren Frank, Adam R Kennedy, Douglas R Porter, Francis E Marino, Fen-Fen Liu, Emmanuel N Pothos, Eleftheria Maratos-Flier. Dysregulation of the mesolimbic dopamine system and reward in MCH-/- mice.
Biological psychiatry.
2008 Aug; 64(3):184-91. doi:
10.1016/j.biopsych.2007.12.011. [PMID: 18281019] - Aloke K Dutta, Balaram Ghosh, Swati Biswas, Maarten E A Reith. D-161, a novel pyran-based triple monoamine transporter blocker: behavioral pharmacological evidence for antidepressant-like action.
European journal of pharmacology.
2008 Jul; 589(1-3):73-9. doi:
10.1016/j.ejphar.2008.05.008. [PMID: 18561912] - Ling-Wei Hsin, Li-Te Chang, Richard B Rothman, Christina M Dersch, Arthur E Jacobson, Kenner C Rice. Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: role of amino, fluoro, hydroxyl, methoxyl, methyl, methylene, and oxo substituents on affinity for the dopamine and serotonin transporters.
Journal of medicinal chemistry.
2008 May; 51(9):2795-806. doi:
10.1021/jm701270n. [PMID: 18393401] - Iain J A Macdougall, Renate Griffith. Pharmacophore design and database searching for selective monoamine neurotransmitter transporter ligands.
Journal of molecular graphics & modelling.
2008 Apr; 26(7):1113-24. doi:
10.1016/j.jmgm.2007.10.003. [PMID: 18023378] - Manoj Mishra, Rohit Kolhatkar, Juan Zhen, Ingrid Parrington, Maarten E A Reith, Aloke K Dutta. Further structural optimization of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine and 1,4-diazabicyclo[3.3.1]nonane derivatives by introducing an exocyclic hydroxyl group: interaction with dopamine, serotonin, and norepinephrine transporters.
Bioorganic & medicinal chemistry.
2008 Mar; 16(6):2769-78. doi:
10.1016/j.bmc.2008.01.009. [PMID: 18249549] - Yoko Hirata, Hiromi Suzuno, Tadamiki Tsuruta, Kentaro Oh-hashi, Kazutoshi Kiuchi. The role of dopamine transporter in selective toxicity of manganese and rotenone.
Toxicology.
2008 Feb; 244(2-3):249-56. doi:
10.1016/j.tox.2007.11.018. [PMID: 18206288] - Teija Koivula, Päivi Marjamäki, Merja Haaparanta, Veronica Fagerholm, Tove Grönroos, Tiina Lipponen, Outi Perhola, Jouko Vepsäläinen, Olof Solin. Ex vivo evaluation of N-(3-[18F]fluoropropyl)-2 beta-carbomethoxy-3 beta-(4-fluorophenyl)nortropane in rats.
Nuclear medicine and biology.
2008 Feb; 35(2):177-83. doi:
10.1016/j.nucmedbio.2007.09.006. [PMID: 18312827] - Yasushi Kiyono, Taku Sugita, Masashi Ueda, Hidekazu Kawashima, Naoki Kanegawa, Yuji Kuge, Yasuhisa Fujibayashi, Hideo Saji. Evaluation of radioiodinated (2S,alphaS)-2-(alpha-(2-iodophenoxy)benzyl)morpholine as a radioligand for imaging of norepinephrine transporter in the heart.
Nuclear medicine and biology.
2008 Feb; 35(2):213-8. doi:
10.1016/j.nucmedbio.2007.11.006. [PMID: 18312831] - Paulo H C Diniz, Janice H Silva, Marcus V Gomez, Cristina Guatimosim, Renato S Gomez. Halothane increases non-vesicular [(3)H]dopamine release from brain cortical slices.
Cellular and molecular neurobiology.
2007 Sep; 27(6):757-70. doi:
10.1007/s10571-007-9162-0. [PMID: 17680357] - Georgianna G Gould, Bryan W Brooks, Alan Frazer. [(3)H] citalopram binding to serotonin transporter sites in minnow brains.
Basic & clinical pharmacology & toxicology.
2007 Sep; 101(3):203-10. doi:
10.1111/j.1742-7843.2007.00100.x. [PMID: 17697042] - F Wuest, M Berndt, K Strobel, J van den Hoff, X Peng, J L Neumeyer, R Bergmann. Synthesis and radiopharmacological characterization of 2beta-carbo-2'-[18F]fluoroethoxy-3beta-(4-bromo-phenyl)tropane ([18F]MCL-322) as a PET radiotracer for imaging the dopamine transporter (DAT).
Bioorganic & medicinal chemistry.
2007 Jul; 15(13):4511-9. doi:
10.1016/j.bmc.2007.04.019. [PMID: 17467995] - Alberto Ambesi-Impiombato, Fabio Panariello, Carmela Dell'aversano, Carmine Tomasetti, Giovanni Muscettola, Andrea de Bartolomeis. Differential expression of Homer 1 gene by acute and chronic administration of antipsychotics and dopamine transporter inhibitors in the rat forebrain.
Synapse (New York, N.Y.).
2007 Jun; 61(6):429-39. doi:
10.1002/syn.20385. [PMID: 17372981] - Nobuyuki Maruoka, Tetsuhito Murata, Naoto Omata, Yasuhiro Takashima, Yasuhisa Fujibayashi, Yuji Wada. Biphasic mechanism of the toxicity induced by 1-methyl-4-phenylpyridinium ion (MPP+) as revealed by dynamic changes in glucose metabolism in rat brain slices.
Neurotoxicology.
2007 May; 28(3):672-8. doi:
10.1016/j.neuro.2007.02.008. [PMID: 17391768] - Nianhang Chen, Maarten E A Reith. Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells.
Journal of neurochemistry.
2007 Apr; 101(2):377-88. doi:
10.1111/j.1471-4159.2006.04384.x. [PMID: 17250655] - Kathleen M Gilbert, Terrence L Boos, Christina M Dersch, Elisabeth Greiner, Arthur E Jacobson, David Lewis, Dorota Matecka, Thomas E Prisinzano, Ying Zhang, Richard B Rothman, Kenner C Rice, Carol A Venanzi. DAT/SERT selectivity of flexible GBR 12909 analogs modeled using 3D-QSAR methods.
Bioorganic & medicinal chemistry.
2007 Jan; 15(2):1146-59. doi:
10.1016/j.bmc.2006.09.070. [PMID: 17127069] - Lisa S Middleton, Subbu Apparsundaram, Kelley A King-Pospisil, Linda P Dwoskin. Nicotine increases dopamine transporter function in rat striatum through a trafficking-independent mechanism.
European journal of pharmacology.
2007 Jan; 554(2-3):128-36. doi:
10.1016/j.ejphar.2006.09.074. [PMID: 17141211] - Anthony S L Chan, Linda W C Ng, Lydia S W Poon, Winnie W Y Chan, Yung H Wong. Dopaminergic and adrenergic toxicities on SK-N-MC human neuroblastoma cells are mediated through G protein signaling and oxidative stress.
Apoptosis : an international journal on programmed cell death.
2007 Jan; 12(1):167-79. doi:
10.1007/s10495-006-0524-8. [PMID: 17136323] - A Storch, Y-I Hwang, G Bringmann, D Feineis, S Ott, R Brückner, J Schwarz. Cytotoxicity of chloral-derived beta-carbolines is not specific towards neuronal nor dopaminergic cells.
Journal of neural transmission (Vienna, Austria : 1996).
2006 Dec; 113(12):1895-901. doi:
10.1007/s00702-006-0495-5. [PMID: 16868795] - Nagendra V Chemuturi, Jon E Haraldsson, Thomas Prisinzano, Maureen Donovan. Role of dopamine transporter (DAT) in dopamine transport across the nasal mucosa.
Life sciences.
2006 Aug; 79(14):1391-8. doi:
10.1016/j.lfs.2006.04.021. [PMID: 16733058] - Keith Chiasson, Benoît Daoust, Daniel Levesque, Maria-Grazia Martinoli. Dopamine D2 agonists, bromocriptine and quinpirole, increase MPP+ -induced toxicity in PC12 cells.
Neurotoxicity research.
2006 Aug; 10(1):31-42. doi:
10.1007/bf03033332. [PMID: 17000468] - Shijun Zhang, Fernando Fernandez, Stuart Hazeldine, Jeffrey Deschamps, Juan Zhen, Maarten E A Reith, Aloke K Dutta. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
Journal of medicinal chemistry.
2006 Jul; 49(14):4239-47. doi:
10.1021/jm0601699. [PMID: 16821783] - Terrence L Boos, Elisabeth Greiner, W Jason Calhoun, Thomas E Prisinzano, Barbara Nightingale, Christina M Dersch, Richard B Rothman, Arthur E Jacobson, Kenner C Rice. Structure-activity relationships of substituted N-benzyl piperidines in the GBR series: Synthesis of 4-(2-(bis(4-fluorophenyl)methoxy)ethyl)-1-(2-trifluoromethylbenzyl)piperidine, an allosteric modulator of the serotonin transporter.
Bioorganic & medicinal chemistry.
2006 Jun; 14(11):3967-73. doi:
10.1016/j.bmc.2006.01.065. [PMID: 16563775] - Sylvie Chalon, Hakan Hall, Wadad Saba, Lucette Garreau, Frédéric Dollé, Christer Halldin, Patrick Emond, Michel Bottlaender, Jean-Bernard Deloye, Julie Helfenbein, Jean-Claude Madelmont, Sylvie Bodard, Zoïa Mincheva, Jean-Claude Besnard, Denis Guilloteau. Pharmacological characterization of (E)-N-(4-fluorobut-2-enyl)-2beta-carbomethoxy-3beta-(4'-tolyl)nortropane (LBT-999) as a highly promising fluorinated ligand for the dopamine transporter.
The Journal of pharmacology and experimental therapeutics.
2006 Apr; 317(1):147-52. doi:
10.1124/jpet.105.096792. [PMID: 16339913] - Ezio Carboni, Alessandra Silvagni, Cinzia Vacca, Gaetano Di Chiara. Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex.
Journal of neurochemistry.
2006 Jan; 96(2):473-81. doi:
10.1111/j.1471-4159.2005.03556.x. [PMID: 16336224] - Gennady B Lapa, Gary D Byrd, Alla A Lapa, Evgeny A Budygin, Steven R Childers, Sara R Jones, Jill J Harp. The synthesis and biological evaluation of dopamine transporter inhibiting activity of substituted diphenylmethoxypiperidines.
Bioorganic & medicinal chemistry letters.
2005 Nov; 15(22):4915-8. doi:
10.1016/j.bmcl.2005.08.028. [PMID: 16165350] - Balachandra K Gorentla, Roxanne A Vaughan. Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation.
Neuropharmacology.
2005 Nov; 49(6):759-68. doi:
10.1016/j.neuropharm.2005.08.011. [PMID: 16181646] - Barbara Nightingale, Christina M Dersch, Terrence L Boos, Elisabeth Greiner, William J Calhoun, Arthur E Jacobson, Kenner C Rice, Richard B Rothman. Studies of the biogenic amine transporters. XI. Identification of a 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) analog that allosterically modulates the serotonin transporter.
The Journal of pharmacology and experimental therapeutics.
2005 Aug; 314(2):906-15. doi:
10.1124/jpet.105.084376. [PMID: 15860577] - Tatyana D Sotnikova, Jean-Martin Beaulieu, Larry S Barak, William C Wetsel, Marc G Caron, Raul R Gainetdinov. Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease.
PLoS biology.
2005 Aug; 3(8):e271. doi:
10.1371/journal.pbio.0030271. [PMID: 16050778] - Shijun Zhang, Juan Zhen, Maarten E A Reith, Aloke K Dutta. Discovery of novel trisubstituted asymmetric derivatives of (2S,4R,5R)-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner.
Journal of medicinal chemistry.
2005 Jul; 48(15):4962-71. doi:
10.1021/jm049021k. [PMID: 16033275] - Maarten E A Reith, Lijuan C Wang, Aloke K Dutta. Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity.
Journal of neuroscience methods.
2005 Apr; 143(1):87-94. doi:
10.1016/j.jneumeth.2004.09.015. [PMID: 15763140] - Julie Broadbent, Kathryn M Kampmueller, Sharon A Koonse. Role of dopamine in behavioral sensitization to ethanol in DBA/2J mice.
Alcohol (Fayetteville, N.Y.).
2005 Feb; 35(2):137-48. doi:
10.1016/j.alcohol.2005.03.006. [PMID: 15963427] - Juan Zhen, Soumen Maiti, Nianhang Chen, Aloke K Dutta, Maarten E A Reith. Interaction between a hydroxypiperidine analogue of 4-(2-benzhydryloxy-ethyl)-1-(4-fluorobenzyl)piperidine and Aspartate 68 in the human dopamine transporter.
European journal of pharmacology.
2004 Dec; 506(1):17-26. doi:
10.1016/j.ejphar.2004.10.028. [PMID: 15588620] - Jianjing Cao, John R Lever, Theresa Kopajtic, Jonathan L Katz, Anh T Pham, Muhsinah L Holmes, Joseph B Justice, Amy Hauck Newman. Novel azido and isothiocyanato analogues of [3-(4-phenylalkylpiperazin-1-yl)propyl]bis(4-fluorophenyl)amines as potential irreversible ligands for the dopamine transporter.
Journal of medicinal chemistry.
2004 Dec; 47(25):6128-36. doi:
10.1021/jm049670w. [PMID: 15566284] - Sárka Manáková, Katja A Puttonen, Atso Raasmaja, Pekka T Männistö. The roles of dopamine transporter and Bcl-2 protein in the protection of CV1-P cells from 6-OHDA-induced toxicity.
Toxicology letters.
2004 Dec; 154(1-2):117-23. doi:
10.1016/j.toxlet.2004.07.007. [PMID: 15475185] - Paul W Czoty, Chinnasamy R Ramanathan, Nicole H Mutschler, Alexandros Makriyannis, Jack Bergman. Drug discrimination in methamphetamine-trained monkeys: effects of monoamine transporter inhibitors.
The Journal of pharmacology and experimental therapeutics.
2004 Nov; 311(2):720-7. doi:
10.1124/jpet.104.071035. [PMID: 15240827] - Norihiro Harada, Hiroyuki Ohba, Dai Fukumoto, Takeharu Kakiuchi, Hideo Tsukada. Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.
Synapse (New York, N.Y.).
2004 Oct; 54(1):37-45. doi:
10.1002/syn.20059. [PMID: 15300883] - Hao-Wei Shen, Yoko Hagino, Hideaki Kobayashi, Keiko Shinohara-Tanaka, Kazutaka Ikeda, Hideko Yamamoto, Toshifumi Yamamoto, Klaus-Peter Lesch, Dennis L Murphy, F Scott Hall, George R Uhl, Ichiro Sora. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
2004 Oct; 29(10):1790-9. doi:
10.1038/sj.npp.1300476. [PMID: 15226739] - Lesley J Bryan-Lluka, Marisa H Papacostas, Filip A Paczkowski, Janet C Wanstall. Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT).
British journal of pharmacology.
2004 Sep; 143(1):63-70. doi:
10.1038/sj.bjp.0705904. [PMID: 15302679] - Jason M Williams, Jeffery D Steketee. Characterization of dopamine transport in crude synaptosomes prepared from rat medial prefrontal cortex.
Journal of neuroscience methods.
2004 Aug; 137(2):161-5. doi:
10.1016/j.jneumeth.2004.02.022. [PMID: 15262056] - Yong Yang, Xing Liu, Jian-Hua Ding, Jing Sun, Yan Long, Fang Wang, Hong-Hong Yao, Gang Hu. Effects of iptakalim on rotenone-induced cytotoxicity and dopamine release from PC12 cells.
Neuroscience letters.
2004 Aug; 366(1):53-7. doi:
10.1016/j.neulet.2004.05.009. [PMID: 15265589] - James K Rowlett, Donna M Platt, Roger D Spealman. Cocaine-like discriminative stimulus effects of heroin: modulation by selective monoamine transport inhibitors.
The Journal of pharmacology and experimental therapeutics.
2004 Jul; 310(1):342-8. doi:
10.1124/jpet.104.065631. [PMID: 14985417] - Kimberly P Lindsey, Kristin M Wilcox, John R Votaw, Mark M Goodman, Christophe Plisson, F Ivy Carroll, Kenner C Rice, Leonard L Howell. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.
The Journal of pharmacology and experimental therapeutics.
2004 Jun; 309(3):959-69. doi:
10.1124/jpet.103.060293. [PMID: 14982963] - Nianhang Chen, Juan Zhen, Maarten E A Reith. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.
Journal of neurochemistry.
2004 May; 89(4):853-64. doi:
10.1111/j.1471-4159.2004.02386.x. [PMID: 15140185] - Alexander Storch, Yu-I Hwang, Debra A Gearhart, J Warren Beach, Edward J Neafsey, Michael A Collins, Johannes Schwarz. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
Journal of neurochemistry.
2004 May; 89(3):685-94. doi:
10.1111/j.1471-4159.2004.02397.x. [PMID: 15086525] - Vincent Castagné, Michaël Rougemont, Michel Cuenod, Kim Q Do. Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat's development induce long-term cognitive deficit: relevance to schizophrenia.
Neurobiology of disease.
2004 Feb; 15(1):93-105. doi:
10.1016/j.nbd.2003.09.005. [PMID: 14751774] - V Valentini, R Frau, G Di Chiara. Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine.
Journal of neurochemistry.
2004 Feb; 88(4):917-27. doi:
10.1046/j.1471-4159.2003.02238.x. [PMID: 14756813] - V Castagné, M Cuénod, K Q Do. An animal model with relevance to schizophrenia: sex-dependent cognitive deficits in osteogenic disorder-Shionogi rats induced by glutathione synthesis and dopamine uptake inhibition during development.
Neuroscience.
2004; 123(4):821-34. doi:
10.1016/j.neuroscience.2003.11.012. [PMID: 14751276]
